NYXH
NYXH
NASDAQ · Health Care

Nyxoah Sa

$3.08
+0.01 (+0.33%)
As of May 16, 2:07 AM ET ·
Financial Highlights (FY 2026)
Revenue
9.24M
Net Income
-83,107,018
Gross Margin
63.1%
Profit Margin
-899.1%
Rev Growth
+48.1%
D/E Ratio
0.86
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 63.1% 63.1% 48.0% 48.0%
Operating Margin -833.2% -749.9% 7.1% 7.9%
Profit Margin -899.1% -854.1% 6.9% 6.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 9.24M 6.24M 96.72M 100.81M
Gross Profit 5.83M 3.94M 46.41M 48.38M
Operating Income -77,008,386 -46,794,644 6.86M 7.92M
Net Income -83,107,018 -50,500,517 6.66M 6.06M
Gross Margin 63.1% 63.1% 48.0% 48.0%
Operating Margin -833.2% -749.9% 7.1% 7.9%
Profit Margin -899.1% -854.1% 6.9% 6.0%
Rev Growth +48.1% +48.1% -2.0% +4.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 24.98M 24.98M 61.10M 61.83M
Total Equity 29.16M 29.16M 75.28M 67.03M
D/E Ratio 0.86 0.86 0.81 0.92
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -76,856,149 -49,296,699 9.82M 10.80M
Free Cash Flow 3.28M 3.57M